- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Pharmacokinetics of Ephedrine and Pseudoephedrine after Oral Administration of Kakkonto to Healthy Male Volunteers
-
- INOTSUME Nobuo
- Division of Clinical Pharmacokinetics, Hokkaido Pharmaceutical University School of Pharmacy, Otaru, Japan
-
- FUKUSHIMA Shoji
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobegakuin University, Kobe, Japan
-
- HAYAKAWA Toru
- Division of Clinical Pharmacokinetics, Hokkaido Pharmaceutical University School of Pharmacy, Otaru, Japan
-
- KISHIMOTO Shuichi
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kobegakuin University, Kobe, Japan
-
- YANAGUIMOTO Hitomi
- Division of Clinical Pharmacokinetics, Hokkaido Pharmaceutical University School of Pharmacy, Otaru, Japan
-
- TODA Takaki
- Division of Clinical Pharmacokinetics, Hokkaido Pharmaceutical University School of Pharmacy, Otaru, Japan
-
- GOTO Nobuyoshi
- Makita Hospital, Sapporo, Japan
-
- IMAI Sumio
- Makita Hospital, Sapporo, Japan
Search this article
Description
The pharmacokinetics of serum ephedrine and pseudoephedrine as the indexed reference ingredients of Kampo Kakkonto (ge-gen-tang in Chinese) were compared after the oral administration of 2.5 g and 3.75 g of Kakkonto extract. The mean maximal serum concentrations of ephedrine and pseudoephedrine obtained after the administration at 3.75 g were 1.50- and 1.58-fold higher (p<0.05), respectively, than those obtained after the administration of 2.5 g, whereas the time required to reach the maximal concentration did not significantly differ between the two doses. The mean areas under the concentration-time curves of ephedrine and pseudoephedrine obtained after the 3.75 g of Kakkonto were 1.31- and 1.48-fold higher (p<0.05), respectively, than those obtained after the 2.5 g dose, while no significant differences were observed in the mean residence time and elimination rate constant of the terminal phase between the doses. Disposition profiles showed that the kinetic behavior of ephedrine and pseudoephedrine were largely linear at the doses examined.
Journal
-
- Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
-
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 40 (3), 79-83, 2009
The Japanese Society of Clinical Pharmacology and Therapeutics
- Tweet
Details 詳細情報について
-
- CRID
- 1390282680343328512
-
- NII Article ID
- 10026157535
-
- NII Book ID
- AN0025404X
-
- ISSN
- 18828272
- 03881601
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed
